1990
DOI: 10.1016/0360-3016(90)90022-c
|View full text |Cite
|
Sign up to set email alerts
|

Radiation injury in the human kidney: A prospective analysis using specific scintigraphic and biochemical endpoints

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
35
1

Year Published

1996
1996
2017
2017

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 85 publications
(40 citation statements)
references
References 33 publications
4
35
1
Order By: Relevance
“…This is entirely consistent with clinical observations of slowly progressive renal damage that can occur over periods of 5 to 10 years after irradiation (41,42). Based on the known profiles for development of renal damage, it is obvious that re-irradiation after large initial doses is unlikely to be feasible.…”
Section: Kidneysupporting
confidence: 84%
“…This is entirely consistent with clinical observations of slowly progressive renal damage that can occur over periods of 5 to 10 years after irradiation (41,42). Based on the known profiles for development of renal damage, it is obvious that re-irradiation after large initial doses is unlikely to be feasible.…”
Section: Kidneysupporting
confidence: 84%
“…47,53 The main complication reported when there is an excess dose is decrease in renal function when the kidney's dose is greater than its tolerance (B). 54 Assessments of the dose received by irradiated organ volume show the tolerance thresholds below which there is no toxicity (B) [55][56][57][58][59][60][61] (D).…”
Section: Pancreatic and Biliary Tract Tumorsmentioning
confidence: 99%
“…Renal irradiation to 23 Gy over a 5-week period is associated with a 5% risk of renal failure at 5 years; the rate increases to 50% after 28 Gy [6]. Dewit et al [7] showed a 3040% decrease in renal function, as assessed by scintigraphy after 3-5 years of administration of 40 Gy in 54 weeks. Radiation nephropathy is a slowly progressive, noninflammatory disease with a wide clinical and histological spectrum, depending on total dose, fractionation schedule, age of the patient, and comorbid factors.…”
Section: Discussionmentioning
confidence: 99%